GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE TO REACH USD 688 MILLION BY 2025, GROWING AT A CAGR OF 8% DURING 2020-2025

Embolic Protection Market Size, Share, & Trends Analysis Report By Product (Filters, Occlusions), By Application (Cardiovascular & Peripheral, Neurovascular), By Indication (SVG, Carotid Artery Diseases, Others), By End-user (Hospitals, Specialty Cardiac Centers, ASCs, Freestanding CATH Labs), By Geography (North America, Europe, APAC, Latin America, and the Middle East & Africa) Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2025

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

286 Pages

icon-table

73 Tables

icon-chart

147 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

16 Companies

icon-market

5 Market Segment

GLOBAL EMBOLIC PROTECTION DEVICES MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (REVENUE) USD 688 Million
CAGR 8% (2020-2025)
Base Year 2019
Forecast Year 2020-2025
Market Segmentation Application (Cardiovascular & Peripheral, Neurovascular), By Indication (SVG, Carotid Artery Diseases, Others), By End-user (Hospitals, Specialty Cardiac Centers, ASCs, Freestanding CATH Labs)
Geographical Analysis North America, Europe, APAC, Latin America, and Middle East & Africa
Countries Covered US, Canada, UK, Germany, France, Spain, Italy, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, and UAE

INDUSTRY INSIGHTS

The global embolic protection devices market size is expected to grow at a CAGR of 8% to reach USD 688 million by 2025. The market is growing mainly due to the rising cardiovascular and neurovascular diseases across the globe. Globally, such diseases are primarily caused by several factors, including obesity, lack of physical activities, and hypertension. Epidemiological studies have reported that cardiac and neuro diseases are recognized as the leading cause of morbidity and mortality worldwide. Several factors influence the growth of the global embolic protection devices market. The rising demand for cerebral embolic protection devices is expected to drive the growth of the market. Growing demand for cerebral protection while performing neurovascular surgeries such as carotid artery stenting is another driving factor for the global embolic protection devices market.

SNIPPETS
  • The hospital end-user segment is expected to achieve an incremental growth of over $100 million by 2025. The growth is due to the high uptake of EPDs in several private and public hospitals across the globe.
  • North America is expected to witness the highest growth rate during the forecast period. The growth is on account of a large patient pool, technological advancements, and better product availability.
  • The increasing preference for minimally-invasive surgeries is one of the key driving factors of the market.

GLOBAL EMBOLIC PROTECTION DEVICES MARKET SEGMENTATION

This research report includes a detailed segmentation by

  • Product
  • Application
  • Indication
  • End-user
  • Geography

INSIGHTS BY PRODUCT

The filter devices segment accounts for the maximum market share. This is due to effective clinical results for percutaneous and transcatheter surgical techniques to treat cardiac and neuro disorders. It is expected to grow at the highest CAGR owing to greater safety and procedural outcomes. The high success rate and the growing patient pool for several cardiac and neuro diseases is likely to influence segment growth. The filter devices have a larger profile than the occlusion devices segment. Availability of latest-generation devices Such as ANGIOGUARD RX Guidewire System, by Cardinal Health & FilterWire EZ by Boston Scientific, is driving the growth of the filter devices segment.

The occlusion devices segment is expected to reach over $100 million by 2025. Improved procedural outcomes for several occlusion devices, which aim to reduce or eliminate distal embolization during percutaneous coronary and carotid interventions, have increased the adoption of occlusion devices.

INSIGHTS BY APPLICATION

The cardiac & peripheral segment is expected to retain its market dominance during the forecast period. Filter or occlusion embolic protection devices have proven clinical benefits and can be used when technically feasible for cardiac & peripheral applications. As a result, there is a huge demand for EPDs for treating CVDs across the globe. While APAC is expected to grow at the highest CAGR, North America is likely to retain dominance in the market.

The demand for several embolic protection devices (EPD) is growing steadily for neuro applications such as Carotid Artery Stenting (CAS). Several major and emerging vendors are offering innovative EPDs to reduce the risk of stroke due to embolic events. Moreover, the availability of integrated and advanced embolic protection devices is likely to drive the growth of the neuro application segment.

INSIGHTS BY INDICATION

Despite potential growth opportunities of EPDs to treat saphenous vein graft (SVG), the recent eruption of the COVID-19 pandemic is causing unprecedented challenges to perform PCI procedures. The spread of the virus has disrupted daily lives with educational and commercial institutions shutting down across cities or countries and travel and large gatherings prohibited.

EPDs have become a standard for anatomically suitable patients undergoing SVG PCI. Therefore, many players have been focusing on the development of clinically advanced EPD for SVG disease over the years. This is increasing the global embolic protection devices market size.

Carotid artery stenting (CAS) is considered as the preferred treatment for patients with symptomatic carotid stenosis. The use of embolic protection devices is feasible and safe for patients with a low incidence of neurology complications. Therefore, several vendors are strategizing to develop and commercialize embolic protection devices for carotid interventions.

INSIGHTS BY END-USER

Healthcare professionals in hospitals use advanced embolic protection stents for cardiac & peripheral and neuro procedures. The market is growing at a healthy rate primarily due to the higher adoption of latest generation EPDs, as a majority of patients prefer to visit hospitals. The aging population and the increasing pool of patient populations with CVDs and neuro disease are the major factors driving the market growth of the hospital segment.

Specialty cardiac centers have a high number of highly skilled cardiac surgeons. They perform modern procedures such as PCI, Transcatheter aortic valve replacement with the embolic protection system. In these centers, a patient can obtain services ranging from diagnosis, treatment, and effective post-surgery follow-up due to the availability of superior infrastructure compared to hospitals. This can be attributed to the highest growth rate of the specialty cardiac center segment.

The ability of ambulatory surgical centers to safely perform complex procedures by following backup protocols is expected to witness steady demand. The demand is growing in developed countries as the end-users are shifting from open surgeries to MI-based surgical techniques. The growth in technological advancements, less invasive surgeries, and outpatient services are contributing to the market growth of ASCs.

INSIGHTS BY GEOGRAPHY

North America is the single largest market for embolic protection companies. The region has become strategically important for several prominent vendors, such as Boston Scientific and Abbott. Medtronic embolic protection devices are expected to be innovative as the company is investing significant expenditure in R&D. The US is the major revenue contributor to the market, accounted for a share of 90% in 2019.

Europe is the second-largest market for embolic protection devices and accounted for a share of 34% in 2019. It is growing at a healthy rate and is expected to grow at a similar pace during the forecast period. Germany, France, the UK, Spain, and Italy are the major revenue contributors to this region.

The APAC region was estimated to have 57% of the global elderly population in 2017. The percentage is projected to increase to 61% by 2050. Such a rapidly growing aging population will have a higher risk of having various cardiac disorders. The aging population will increase the demand for these devices during the forecast period.

INSIGHTS BY VENDORS

The global embolic protection devices market share is highly concentrated. The market has the presence of few established players holding the majority of the market share. Vendors are offering several filter and occlusion embolic protection devices. They are competing based on factors such as technology advances, safety features, regulatory approvals, marketing strategies, and distribution channels.

Boston Scientific, Abbott Laboratories, and Medtronic are the key vendors in the global market. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on product innovations and R&D. Medtronic’s spiderfx device offers optimal vessel sizing.

The global embolic protection devices market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

 By Product 

  • Filters
  • Occlusions

By Application 

  • Cardiovascular & Peripheral
  • Neurovascular

By Indication 

  • SVG
  • Carotid Artery Diseases
  • Others
    • Aortic Stenosis
    • Peripheral Artery Disease
    • Acute Myocardial Infraction 

By End-user 

  • Hospitals
  • Specialty Cardiac Centers
  • ASCs
  • Freestanding CATH Labs

By Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Frequently Asked Questions

What is the global embolic protection devices market size and growth forecast?

Embolic protection devices market size is expected reach revenues of over USD 688 million by 2025.

What are the factors impacting the growth of the embolic protection devices market?

The rising demand for cerebral embolic protection devices is expected to drive the growth of the market.

Who are the leading vendors and what are their market shares?

Boston Scientific, Abbott Laboratories, and Medtronic are the key vendors in the global market.

What are the factors impacting the growth of North America embolic protection devices market?

North America is expected to witness the highest growth rate during the forecast period.

Download Free Sample

The embolic protection devices market share is expected to grow at a CAGR of over 8% during the period 2020–2025.

 The following factors are likely to contribute to the growth of the embolic protection devices market during the forecast period:

  • Emergence of Advanced Embolic Protection Devices
  • New Product Approvals
  • Demand for Cerebral Embolic Protection Devices 

Base Year:                  2019

Forecast Year:           2020–2025

The study considers the present scenario of the embolic protection devices market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Prominent Vendors

  • Boston Scientific
    • Business Overview
    • Major Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Abbott
  • Medtronic

Other Prominent Vendors 

  • Cardinal Health
    • Business Overview
    • Major Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • Cardiovascular Systems
  • Contego Medical
  • InspireMD
  • NIPRO
  • Silk Road Medical
  • Terumo
  • Venus Medtech

Investigational Companies 

  • Cardiotimus
    • Business Overview
    • Investigational Products
  • Filterlex
  • Innovative Cardiovascular Solutions
  • Protembis
  • Transverse Medical

Segmentation by Product 

  • Filters
  • Occlusions 

Segmentation by Application 

  • Cardiovascular & Peripheral
  • Neurovascular 

Segmentation by Indication 

  • SVG
  • Carotid Artery Diseases
  • Others
    • Aortic Stenosis
    • Peripheral Artery Disease
    • Acute Myocardial Infraction 

Segmentation by End-user 

  • Hospitals
  • Specialty Cardiac Centers
  • ASCs
  • Freestanding CATH Labs

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

1              Research Methodology

2              Research Objectives

3              Research Process

 

4              Scope & Coverage

4.1          Market Definition

4.1.1      Inclusions

4.1.2      Exclusion

4.2          Base Year

4.3          Scope Of The Study

4.4          Markey Segments

4.4.1      Market Segmentation by Product

4.4.2      Market Segmentation by Application

4.4.3      Market Segmentation by Indication

4.4.4      Market Segmentation by End-user

4.4.5      Market Segmentation by Geography

 

5              Report Assumptions & Caveats

5.1          Key Caveats

5.2          Currency Conversion

5.3          Market Derivation

 

6              Market at a Glance

7              Introduction

7.1          Embolic Protection Devices (EPDS): An Overview

7.1.1      Background

7.1.2      Use of EPDs

 

8              Market Opportunities & Trends

8.1          Emergence Of Advanced EPDs

8.2          Promising Investigational Devices

8.3          New Product Approval

 

9              Market Growth Enablers

9.1          Rising Patient Pool

9.2          Growing Demand For Cerebral Embolic Protection Devices

9.3          Rising Demand For Minimally Invasive Vascular Surgeries

 

10           Market Restraints

10.1        Stringent Regulations & Product Recalls

10.2        Risk & Complications Associated With Embolic Protection Devices

10.2.1    Complications Associated With Cardiovascular & Peripheral Procedures

10.2.2    Complications Associated With Neurovascular Procedures

10.3        Lower Than Expected Acceptance & Clinical Implementation

 

11           Market Landscape

11.1        Market Overview

11.2        Market Size & Forecast

11.2.1    Geographic Analysis

11.2.2    Product Analysis

11.2.3    Application Analysis

11.2.4    Indication Analysis

11.2.5    End User Analysis

11.3        Five Forces Analysis

11.3.1    Threat of New Entrants

11.3.2    Bargaining Power of Suppliers

11.3.3    Bargaining Power of Buyers

11.3.4    Threat of Substitutes

11.3.5    Competitive Rivalry

 

12           Product

12.1        Market Snapshot & Growth Engine

12.2        Market Overview

12.3        Filter Devices

12.3.1    Market Overview

12.3.2    Market Size & Forecast

12.4        Occlusion Devices

12.4.1    Market Overview

12.4.2    Market Size & Forecast

 

13           Application

13.1        Market Snapshot & Growth Engine

13.2        Market Overview

13.3        Cardiovascular & Peripheral Applications

13.3.1    Market Overview

13.3.2    Market Size & Forecast

13.3.3    Geographic Market Snapshot & Growth Engine

13.4        Neurovascular Application

13.4.1    Market Overview

13.4.2    Market Size & Forecast

13.4.3    Geographic Market Snapshot & Growth Engine

 

14           Indication

14.1        Market Snapshot & Growth Engine

14.2        Market Overview

14.3        SVG

14.3.1    Market Overview

14.3.2    Market Size & Forecast

14.4        Carotid Artery Disease

14.4.1    Market Overview

14.4.2    Market Size & Forecast

14.5        Others

14.5.1    Market Overview

14.5.2    Market Size & Forecast

 

15           End-User

15.1        Market Snapshot & Growth Engine

15.2        Market Overview

15.3        Hospitals

15.3.1    Market Overview

15.3.2    Market Size & Forecast

15.4        Specialty Cardiac Centers

15.4.1    Market Overview

15.4.2    Market Size & Forecast

15.5        ASCS

15.5.1    Market Overview

15.5.2    Market Size & Forecast

15.6        Freestanding Cath Labs

15.6.1    Market Overview

15.6.2    Market Size & Forecast

 

16           Geography

16.1        Market Snapshot & Growth Engine

16.2        Geographic Overview

 

17           North America

17.1        Market Overview

17.2        Market Size & Forecast

17.3        Application Segmentation

17.3.1    Market Snapshot & Growth Engine

17.4        Key Countries

17.4.1    US: Market Size & Forecast

17.4.2    Canada: Market Size & Forecast

 

18           Europe

18.1        Market Overview

18.2        Market Size & Forecast

18.3        Application Segmentation

18.3.1    Market Snapshot & Growth Engine

18.4        Key Countries

18.4.1    Germany: Market Size & Forecast

18.4.2    France: Market Size & Forecast

18.4.3    UK: Market Size & Forecast

18.4.4    Spain: Market Size & Forecast

18.4.5    Italy: Market Size & Forecast

 

19           APAC

19.1        Market Overview

19.2        Market Size & Forecast

19.3        Application Segmentation

19.3.1    Market Snapshot & Growth Engine

19.4        Key Countries

19.4.1    Japan: Market Size & Forecast

19.4.2    China: Market Size & Forecast

19.4.3    Australia: Market Size & Forecast

19.4.4    South Korea: Market Size & Forecast

19.4.5    India: Market Size & Forecast

 

20           Latin America

20.1        Market Overview

20.2        Market Size & Forecast

20.3        Application Segmentation

20.3.1    Market Snapshot & Growth Engine

20.4        Key Countries

20.4.1    Brazil: Market Size & Forecast

20.4.2    Mexico: Market Size & Forecast

20.4.3    Argentina: Market Size & Forecast

 

21           Middle East & Africa

21.1        Market Overview

21.2        Market Size & Forecast

21.3        Application Segmentation

21.3.1    Market Snapshot & Growth Engine

21.4        Key Countries

21.4.1    Turkey: Market Size & Forecast

21.4.2    Saudi Arabia: Market Size & Forecast

21.4.3    South Africa: Market Size & Forecast

 

22           Competitive Landscape

22.1        Competition Overview

22.2        Market Share Analysis

22.2.1    Boston Scientific

22.2.2    Abbott

22.2.3    Medtronic

 

23           Key Company Profiles

23.1        Boston Scientific

23.1.1    Business Overview

23.1.2    Product Offerings

23.1.3    Key Strategies

23.1.4    Key Strengths

23.1.5    Key Opportunities

23.2        Abbott

23.2.1    Business Overview

23.2.2    Product Offerings

23.2.3    Key Strategies

23.2.4    Key Strengths

23.2.5    Key Opportunities

23.3        Medtronic

23.3.1    Business Overview

23.3.2    Product Offerings

23.3.3    Key Strategies

23.3.4    Key Strengths

23.3.5    Key Opportunities

 

24           Other Prominent Vendors

24.1        Cardinal Health

24.1.1    Business Overview

24.1.2    Product Offerings

24.1.3    Key Strategies

24.1.4    Key Strengths

24.1.5    Key Opportunities

24.2        Cardiovascular Systems

24.2.1    Business Overview

24.2.2    Product Offerings

24.2.3    Key Strategies

24.2.4    Key Strengths

24.2.5    Key Opportunities

24.3        Contego Medical

24.3.1    Business Overview

24.3.2    Product Offerings

24.3.3    Key Strategies

24.3.4    Key Strengths

24.3.5    Key Opportunities

24.4        InspireMD

24.4.1    Business Overview

24.4.2    Product Offerings

24.4.3    Key Strategies

24.4.4    Key Strengths

24.4.5    Key Opportunities

24.5        NIPRO

24.5.1    Business Overview

24.5.2    Product Offerings

24.5.3    Key Strategies

24.5.4    Key Strengths

24.5.5    Key Opportunities

24.6        Silk Road Medical

24.6.1    Business Overview

24.6.2    Product Offerings

24.6.3    Key Strategies

24.6.4    Key Strengths

24.6.5    Key Opportunities

24.7        Terumo

24.7.1    Business Overview

24.7.2    Product Offerings

24.7.3    Key Strategies

24.7.4    Key Strengths

24.7.5    Key Opportunities

24.8        Venus Medtech

24.8.1    Business Overview

24.8.2    Product Offerings

24.8.3    Key Strategies

24.8.4    Key Strengths

24.8.5    Key Opportunities 

 

25           Investigational Companies

25.1        Cardioptimus

25.1.1    Business Overview

25.1.2    Investigational Products

25.2        filterlex

25.2.1    Business Overview

25.2.2    Investigational Products

25.3        Innovative Cardiovascular Solutions

25.3.1    Business Overview

25.3.2    Investigational Products

25.4        Protembis

25.4.1    Business Overview

25.4.2    Investigational Products

25.5        Transverse Medical

25.5.1    Business Overview

25.5.2    Investigational Products

 

26           Report Summary

26.1        Key Takeaways

26.2        Strategic Recommendations

27           Quantitative Summary

27.1        Product

27.2        Application

27.3        Indication

27.4        End-User

27.5        Geography

27.6        North America: Application Segmentation

27.7        Europe: Application Segmentation

27.8        Apac: Application Segmentation

27.9        Latin America: Application Segmentation

27.1        Middle East & Africa: Application Segmentation

27.11     Cardiovascular & Peripheral: Geography Segmentation

27.12     Neurovascular: Geography Segmentation

 

28           Appendix

28.1        Abbreviations

List Of Exhibits 

Exhibit 1               Segmentation of Global Embolic Protection Devices Market

Exhibit 2               Market Size Calculation Approach 2019

Exhibit 3               Classification of EPDs

Exhibit 4               Key Advantages of Embolic Protection Devices

Exhibit 5               Key Application Areas of EPDs

Exhibit 6               Major Market Dynamics of EPDs

Exhibit 7               Global Embolic Protection Devices Market by Geography 2019 (%)

Exhibit 8               Global Embolic Protection Devices Market by Product 2019 (%)

Exhibit 9               Impact of Emergence of Advanced EPDs

Exhibit 10             Impact of Promising Investigational Devices

               

Exhibit 11             Impact of New Product Approval

Exhibit 12             Impact of Rising Patient Pool

Exhibit 13             Prevalence of Aortic Valve Disease in Different Age Groups (%)

Exhibit 14             Prevalence of Aortic Regurgitation in Different Age groups

Exhibit 15             Impact of Growing Demand for Cerebral Embolic Protection Devices

Exhibit 16             Impact of Rising Demand for Minimally Invasive Vascular Surgeries

Exhibit 17             The MI Approach for Embolic Protection Devices Offers

Exhibit 18             Impact of Stringent Regulations & Product Recalls

Exhibit 19             Major Actions/Sanctions Imposed on Manufacturers by Regulatory Bodies

Exhibit 20             Impact of Risk & Complications Associated with Embolic Protection Devices

Exhibit 21             Impact of Lower Than Expected Acceptance & Clinical Implementation

Exhibit 22             Key Factors Hindering the Expected Market Penetration of EPDs in Developing Countries

Exhibit 23             Global Embolic Protection Devices Market Share by Region 2019 (%)

Exhibit 24             Global Embolic Protection Devices Market 2019–2025 ($ million)

Exhibit 25             Global Embolic Protection Devices Market by Geography

Exhibit 26             Global Embolic Protection Devices Market by Product

Exhibit 27             Global Embolic Protection Devices Market by Application

Exhibit 28             Global Embolic Protection Devices Market by Indication

Exhibit 29             Global Embolic Protection Devices Market by End-user

Exhibit 30             Five Forces Analysis 2019

Exhibit 31             Incremental Growth by Product 2019 & 2025

Exhibit 32             Global Embolic Protection Devices Market by Product

Exhibit 33             Global Embolic Protection Devices Market by Product: Incremental Growth

Exhibit 34             Global Embolic Protection Devices Market by Product: Absolute Growth

Exhibit 35             Global Filter Embolic Protection Devices Market: Incremental & Absolute Growth

Exhibit 36             Key Advantages of Filter Devices for Embolic Protection

Exhibit 37             Global Filter Embolic Protection Devices Market 2019–2025 ($ million)

Exhibit 38             Global Occlusion Embolic Protection Devices Market: Incremental & Absolute Growth

Exhibit 39             Key Advantages of Occlusion Devices

Exhibit 40             Global Occlusion Embolic Protection Devices Market 2019–2025 ($ million)

Exhibit 41             Incremental Growth by Application 2019 & 2025

Exhibit 42             Global Embolic Protection Devices Market by Application

Exhibit 43             Global Embolic Protection Devices Market by Application: Incremental Growth

Exhibit 44             Global Embolic Protection Devices Market by Application: Absolute Growth

Exhibit 45             Global Cardiovascular & Peripheral Embolic Protection Devices Market: Incremental & Absolute Growth

Exhibit 46             Global Embolic Protection Devices Market for Cardiovascular & Peripheral Applications 2019–2025 ($ million)

Exhibit 47             Benefits of Prevention of Microvascular Obstruction with Embolic Protection Devices in SVG PCI

Exhibit 48             Incremental Growth by Geography 2019 & 2025

Exhibit 49             Cardiovascular & Peripheral Embolic Protection Devices Market by Geography 2019 & 2025 (%)

Exhibit 50             Neurovascular Embolic Protection Devices Market: Incremental & Absolute Growth

Exhibit 51             Global Embolic Protection Devices Market for Neurovascular Application 2019–2025 ($ million)

Exhibit 52             Incremental Growth by Geography 2019 & 2025

Exhibit 53             Global Neurovascular Embolic Protection Devices Market by Geography 2019 & 2025 (%)

Exhibit 54             Incremental Growth by Indication 2019 & 2025

Exhibit 55             Global Embolic Protection Devices Market by Indication

Exhibit 56             Global Embolic Protection Devices Market by Indication: Incremental Growth

Exhibit 57             Global Embolic Protection Devices Market by Indication: Absolute Growth

Exhibit 58             Global Embolic Protection Devices Market for SVG: Incremental & Absolute Growth

Exhibit 59             Key Strengths of EPDs for SVG

Exhibit 60             Global Embolic Protection Devices Market for SVG 2019–2025 ($ million)

Exhibit 61             Embolic Protection Devices Market for Carotid Artery Disease: Incremental & Absolute Growth

Exhibit 62             Global Embolic Protection Devices Market for Carotid Artery Disease 2019–2025 ($ million)

Exhibit 63             Global Embolic Protection Devices Market for Other Indications: Incremental & Absolute Growth

Exhibit 64             Potential Advantages of EPDs for TAVR Procedure

Exhibit 65             Global Embolic Protection Devices Market for Other Indications 2019–2025 ($ million)

Exhibit 66             Incremental Growth by End-user 2019 & 2025

Exhibit 67             Global Embolic Protection Devices Market by End-user

Exhibit 68             Global Embolic Protection Devices Market by End-user: Incremental Growth

Exhibit 69             Global Embolic Protection Devices Market by End-user: Absolute Growth

Exhibit 70             Global Embolic Protection Devices Market by Hospitals: Incremental & Absolute Growth

Exhibit 71             Global Embolic Protection Devices Market by Hospitals 2019–2025 ($ million)

Exhibit 72             Global Embolic Protection Devices Market by Specialty Cardiac Centers: Incremental & Absolute Growth

Exhibit 73             Global Embolic Protection Devices Market by Specialty Cardiac Centers 2019–2025 ($ million)

Exhibit 74             Global Embolic Protection Devices Market by ASCs: Incremental & Absolute Growth

Exhibit 75             Global Embolic Protection Devices Market by ASCs 2019–2025 ($ million)

Exhibit 76             Global Embolic Protection Devices Market by Freestanding CATH Labs: Incremental & Absolute Growth

Exhibit 77             Global Embolic Protection Devices Market by Freestanding CATH Labs 2019–2025 ($ million)

Exhibit 78             Incremental Growth by Geography 2019 & 2025

Exhibit 79             Global Embolic Protection Devices Market by Geography

Exhibit 80             Global Embolic Protection Devices Market by Geography 2019: Key Countries ($ million)

Exhibit 81             Global Embolic Protection Devices Market by Geography: Incremental Growth

Exhibit 82             Global Embolic Protection Devices Market by Geography: Absolute Growth

Exhibit 83             Embolic Protection Devices Market in North America: Key Countries 2019 ($ million)

Exhibit 84             North America Embolic Protection Devices Market: Absolute & Incremental Growth

Exhibit 85             Embolic Protection Devices Market in North America 2019–2025 ($ million)

Exhibit 86             Incremental Growth by Application 2019 & 2025

Exhibit 87             North America Embolic Protection Devices Market by Application 2019 & 2025 (%)

Exhibit 88             Incremental Growth in North America 2019 & 2025

Exhibit 89             Embolic Protection Devices Market in US 2019–2025 ($ million)

Exhibit 90             Embolic Protection Devices Market in Canada 2019–2025 ($ million)

Exhibit 91             Embolic Protection Devices Market in Europe: Key Countries 2019 ($ million)

Exhibit 92             Embolic Protection Devices Market in Europe: Incremental & Absolute Growth

Exhibit 93             Embolic Protection Devices Market in Europe 2019–2025 ($ million)

Exhibit 94             Incremental Growth by Application 2019 & 2025

Exhibit 95             Embolic Protection Devices Market in Europe by Application 2019 & 2025 (%)

Exhibit 96             Incremental Growth in Europe 2019 & 2025

Exhibit 97             Embolic Protection Devices Market in Germany 2019–2025 ($ million)

Exhibit 98             Embolic Protection Devices Market in France 2019–2025 ($ million)

Exhibit 99             Embolic Protection Devices Market in UK 2019–2025 ($ million)

Exhibit 100          Embolic Protection Devices Market in Spain 2019–2025 ($ million)

Exhibit 101          Embolic Protection Devices Market in Italy 2019–2025 ($ million)

Exhibit 102          Embolic Protection Devices Market in APAC: Key Countries 2019 ($ million)

Exhibit 103          Embolic Protection Devices Market in APAC: Incremental & Absolute Growth

Exhibit 104          Embolic Protection Devices Market in APAC 2019–2025 ($ million)

Exhibit 105          Health Access & Quality Index Score for Key APAC Countries 2016

Exhibit 106          Incremental Growth by Application 2019 & 2025

Exhibit 107          Embolic Protection Devices Market in APAC by Application 2019 & 2025 (%)

Exhibit 108          Incremental Growth in APAC 2019 & 2025

Exhibit 109          Embolic Protection Devices Market in Japan 2019–2025 ($ million)

Exhibit 110          Embolic Protection Devices Market in China 2019–2025 ($ million)

Exhibit 111          Embolic Protection Devices Market in Australia 2019–2025 ($ million)

Exhibit 112          Embolic Protection Devices Market in South Korea 2019–2025 ($ million)

Exhibit 113          Embolic Protection Devices Market in India 2019–2025 ($ million)

Exhibit 114          Embolic Protection Devices Market in Latin America: Key Countries 2019 ($ million)

Exhibit 115          Embolic Protection Devices Market in Latin America: Incremental & Absolute Growth

Exhibit 116          Embolic Protection Devices Market in Latin America 2019–2025 ($ million)

Exhibit 117          Incremental Growth by Application 2019 & 2025

Exhibit 118          Latin America Embolic Protection Devices Market by Application 2019 & 2025 (%)

Exhibit 119          Incremental Growth in Latin America 2019 & 2025

Exhibit 120          Embolic Protection Devices Market in Brazil 2019–2025 ($ million)

Exhibit 121          Embolic Protection Devices Market in Mexico 2019–2025 ($ million)

Exhibit 122          Embolic Protection Devices Market in Argentina 2019–2025 ($ million)

Exhibit 123          Embolic Protection Devices Market in Middle East & Africa: Key Countries 2019 ($ million)

Exhibit 124          Embolic Protection Devices Market in Middle East & Africa: Incremental & Absolute Growth

Exhibit 125          Embolic Protection Devices Market in Middle East & Africa 2019–2025 ($ million)

Exhibit 126          Incremental Growth by Application 2019 & 2025

Exhibit 127          Embolic Protection Devices Market in Middle East & Africa by Application 2019 & 2025 (%)

Exhibit 128          Incremental Growth in Middle East & Africa 2019 & 2025

Exhibit 129          Embolic Protection Devices Market in Turkey 2019–2025 ($ million)

Exhibit 130          Embolic Protection Devices Market in Saudi Arabia 2019–2025 ($ million)

Exhibit 131          Embolic Protection Devices Market in South Africa 2019–2025 ($ million)

Exhibit 132          Market Share (2019)

Exhibit 133          Boston Scientific: R&D Expenditure 2017−2019 ($ million)

Exhibit 134          Boston Scientific: Revenue by Business Segments 2018 & 2019 ($ million)

Exhibit 135          Boston Scientific: Revenue by Geography 2019 (%)

Exhibit 136          Abbott: R&D Expenditure 2017−2019 ($ million)

Exhibit 137          Abbott: Revenue by Segments 2018 & 2019 ($ million)

Exhibit 138          Abbott: Revenue by Geography 2019 (%)

Exhibit 139          Medtronic: R&D Expenditure 2017−2019 ($ million)

Exhibit 140          Medtronic: Revenue by Segment 2018 & 2019 ($ million)

Exhibit 141          Medtronic: Revenue by Geography 2019 (%)

Exhibit 142          Cardinal Health: Revenue by Segment 2018 & 2019 ($ million)

Exhibit 143          Cardinal Health: Revenue by Geography 2019 (%)

Exhibit 144          Cardiovascular Systems: R&D Expenditure 2017−2019 ($ million)

Exhibit 145          Cardiovascular Systems: Revenue by Product Type 2018 & 2019 ($ million)

Exhibit 146          Cardiovascular Systems: Revenue by Geography 2019 (%)

Exhibit 147          InspireMD: R&D Expenditure 2017−2019 ($ million)

               

List Of Tables    

Table 1                  Key Caveats

Table 2                  Currency Conversion 2013−2019

Table 3                  Key Advanced Embolic Protection Devices

Table 4                  Major Embolic Protection Devices Pipeline

Table 5                  List of New Product Approval

Table 6                  Mechanisms of Stroke in TAVR Patients

Table 7                  Key Cerebral Embolic Protection Devices Offered by Significant Vendors

Table 8                  Key Investigational Cerebral Embolic Protection Devices

Table 9                  Significant Product Recalls

Table 10               Market Penetration of EPDs by Region 2019 (%)

Table 11               Key Embolic Protection Filter Devices

Table 12               Significant Occlusion Embolic Protection Devices Offered by Market Players

Table 13               Key Cardiovascular & Peripheral EPDs Offered by Significant Players

Table 14               Cardiovascular & Peripheral Embolic Protection Devices Market by Geography 2019−2025 ($ million)

Table 15               Cardiovascular & Peripheral Embolic Protection Devices Market by Geography 2019−2025 (%)

Table 16               Key Neurovascular EPDs Offered by Significant Players

Table 17               Global Neurovascular Embolic Protection Devices Market by Geography 2019−2025 ($ million)

Table 18               Global Neurovascular Embolic Protection Devices Market by Geography 2019−2025 (%)

Table 19               Vendors Offering EPDs for SVG Indications

Table 20               Vendors Offering EPDs for Carotid Artery Disease

Table 21               North America Embolic Protection Devices Market by Application 2019−2025 ($ million)

Table 22               North America Embolic Protection Devices Market by Application 2019−2025 (%)

Table 23               Europe Embolic Protection Devices Market in Europe by Application 2019−2025 ($ million)

Table 24               Embolic Protection Devices Market in Europe by Application 2019−2025 (%)

Table 25               Embolic Protection Devices Market in APAC by Application 2019−2025 ($ million)

Table 26               Embolic Protection Devices Market in APAC by Application 2019−2025 (%)

Table 27               Provincial Reimbursement Policy in China

Table 28               Latin America Embolic Protection Devices Market by Application 2019−2025 ($ million)

Table 29               Latin America Embolic Protection Devices Market by Application 2019−2025 (%)

Table 30               Embolic Protection Devices Market in Middle East & Africa by Application 2019−2025 ($ million)

Table 31               Embolic Protection Devices Market in Middle East & Africa by Application 2019−2025 (%)

Table 32               Competitive Structure of Global Embolic Protection Devices Market

Table 33               Global Embolic Protection Devices Market: Vendors Ranking 2019

Table 34               Boston Scientific: Major Product Offerings

Table 35               Abbott: Major Product Offerings

Table 36               Medtronic: Major Product Offerings

Table 37               Cardinal Health: Major Product Offerings

Table 38               Cardiovascular Systems: Major Product Offerings

Table 39               Contego Medical: Major Product Offerings

Table 40               InspireMD: Major Product Offerings

Table 41               NIPRO: Major Product Offerings

Table 42               Silk Road Medical: Major Product Offerings

Table 43               Terumo: Major Product Offerings

Table 44               Venus Medtech: Major Product Offerings

Table 45               Cardioptimus: Major Investigational Products

Table 46               Filterlex: Major Investigational Products

Table 47               Innovative Cardiovascular Solutions: Major Investigational Products

Table 48               Protembis: Major Investigational Products

Table 49               Transverse Medical: Major Investigational Products

Table 50               Global Embolic Protection Devices Market by Product 2019−2025 ($ million)

Table 51               Global Embolic Protection Devices Market by Product 2019−2025 (%)

Table 52               Global Embolic Protection Devices Market by Application 2019−2025 ($ million)

Table 53               Global Embolic Protection Devices Market by Application 2019−2025 (%)

Table 54               Global Embolic Protection Devices Market by Indication 2019−2025 ($ million)

Table 55               Global Embolic Protection Devices Market by Indication 2019−2025 (%)

Table 56               Global Embolic Protection Devices Market by End-user 2019−2025 ($ million)

Table 57               Global Embolic Protection Devices Market by End-user 2019−2025 (%)

Table 58               Global Embolic Protection Devices Market by Geography 2019−2025 ($ million)

Table 59               Global Embolic Protection Devices Market by Geography 2019−2025 (%)

Table 60               North America Embolic Protection Devices Market by Application 2019−2025 ($ million)

Table 61               North America Embolic Protection Devices Market by Application 2019−2025 (%)

Table 62               Europe Embolic Protection Devices Market by Application 2019−2025 ($ million)

Table 63               Europe Embolic Protection Devices Market by Application 2019−2025 (%)

Table 64               APAC Embolic Protection Devices Market by Application 2019−2025 ($ million)

Table 65               APAC Embolic Protection Devices Market by Application 2019−2025 (%)

Table 66               Latin America Embolic Protection Devices Market by Application 2019−2025 ($ million)

Table 67               Latin America Embolic Protection Devices Market by Application 2019−2025 (%)

Table 68               Middle East & Africa Embolic Protection Devices Market by Application 2019−2025 ($ million)

Table 69               Middle East & Africa Embolic Protection Devices Market by Application 2019−2025 (%)

Table 70               Cardiovascular & Peripheral Embolic Protection Devices Market by Geography 2019−2025 ($ million)

Table 71               Cardiovascular & Peripheral Embolic Protection Devices Market by Geography 2019−2025 (%)

Table 72               Neurovascular Embolic Protection Devices Market by Geography 2019−2025 ($ million)

Table 73               Neurovascular Embolic Protection Devices Market by Geography 2019−2025 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4000.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5000.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date